PRO1107 in Patients With Advanced Solid Tumors

Clinical trial NCT06171789 · TERMINATED

Trial details

NCT number: NCT06171789
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer Ovarian Cancer Triple Negative Breast Cancer GastroEsophageal Cancer Non-small Cell Lung Cancer Urothelial Carcinoma

Start date: 2024-01-03
Primary completion: 2025-08-18
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.